Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Romanian Journal of Internal Medicine
Volume 55 (2017): Numero 2 (June 2017)
Accesso libero
Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania
Ioana Frinc
Ioana Frinc
,
Petru Ilies
Petru Ilies
,
Florin Zaharie
Florin Zaharie
,
Delia Dima
Delia Dima
,
Alina Tanase
Alina Tanase
,
Ljubomir Petrov
Ljubomir Petrov
,
Alexandru Irimie
Alexandru Irimie
,
Cristian Berce
Cristian Berce
,
Cosmin Lisencu
Cosmin Lisencu
,
Ioana Berindan-Neagoe
Ioana Berindan-Neagoe
,
Ciprian Tomuleasa
Ciprian Tomuleasa
e
Anca Bojan
Anca Bojan
| 06 giu 2017
Romanian Journal of Internal Medicine
Volume 55 (2017): Numero 2 (June 2017)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
06 giu 2017
Pagine:
103 - 116
Ricevuto:
05 ott 2016
DOI:
https://doi.org/10.1515/rjim-2017-0006
Parole chiave
hematological malignancies
,
immunosuppression
,
transthoracic ultrasound
,
antibiotics
,
antifungal treatment
© 2017 Ioana Frinc et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ioana Frinc
Department of Hematology, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Department of Hematology, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Petru Ilies
Department of Internal Medicine, 5,Medical Clinic
Cluj-Napoca, Romania
Florin Zaharie
Department of Surgery, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Delia Dima
Department of Hematology, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Alina Tanase
Department of Stem Cell Transplantation, Fundeni Clinical Institute
Bucharest, Romania
Ljubomir Petrov
Department of Hematology, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Alexandru Irimie
Department of Surgery, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Cristian Berce
Department of Surgery, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Cosmin Lisencu
Department of Surgery, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Ioana Berindan-Neagoe
Department of Genetics, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Ciprian Tomuleasa
Department of Hematology, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Department of Hematology, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania
Anca Bojan
Department of Hematology, “Ion Chiricuţă” Oncology Institute
Cluj-Napoca, Romania
Department of Hematology, “Iuliu Haţieganu” University of Medicine and Pharmacy
Cluj-Napoca, Romania